Skip to main content
Erschienen in: Virchows Archiv 2/2009

01.02.2009 | Original Article

Active neovascularization and possible vascular-centric development of gastric and periscapular elastofibromas

verfasst von: Keita Kai, Kenichiro Kusano, Masashi Sakai, Masanobu Tabuchi, Seiji Yunotani, Kohji Miyazaki, Osamu Tokunaga

Erschienen in: Virchows Archiv | Ausgabe 2/2009

Einloggen, um Zugang zu erhalten

Abstract

An elastofibroma is a benign and rare fibrous lesion that most commonly occurs in the periscapular region. A gastrointestinal elastofibroma is extremely rare. In the present study, six cases of elastofibromas including a case in the stomach were evaluated. The gastric case revealed widely distributed lesions in the submucosal layer with perivascular fibrotic lesions (PVFLs) and some PVFLs were distributed to the skip lesions of elastofibroma. These PVFLs were also observed in all five periscapular cases and invariably contained elastic fibers which showed various degree of maturation. CD34-positive stromal cells were observed not only in elastofibromas but also in PVFLs in each case. These findings suggested the possibility of the PVFLs were the primary lesions of elastofibroma and their vascular-centric development. The percentage of the CD105-positive vessels in elastofibroma group was significantly higher than in the control group. This result indicates active neovascularization in elastofibromas.
Literatur
1.
Zurück zum Zitat Järvi OH, Saxén AE (1961) Elastofibroma dorse. Acta Pathol Microbiol Scand Suppl 51(Suppl 144):83–84PubMed Järvi OH, Saxén AE (1961) Elastofibroma dorse. Acta Pathol Microbiol Scand Suppl 51(Suppl 144):83–84PubMed
2.
Zurück zum Zitat Kempson RL, Fletcher CD, Evans HL et al (2001) Atlas of tumor pathology tumors of the soft tissues. Armed forces Institute of Pathology, Washington, DC, pp 45–47 Kempson RL, Fletcher CD, Evans HL et al (2001) Atlas of tumor pathology tumors of the soft tissues. Armed forces Institute of Pathology, Washington, DC, pp 45–47
3.
Zurück zum Zitat Fukuda Y, Miyake H, Masuda Y et al (1987) Histogenesis of unique elastinophilic fibers of elastofibroma: ultrastructural and immunohistochemical studies. Hum Pathol 18:424–429PubMedCrossRef Fukuda Y, Miyake H, Masuda Y et al (1987) Histogenesis of unique elastinophilic fibers of elastofibroma: ultrastructural and immunohistochemical studies. Hum Pathol 18:424–429PubMedCrossRef
4.
Zurück zum Zitat Nakamura Y, Okamoto K, Tanimura A et al (1986) Elastase digestion and biochemical analysis of the elastin from an elastofibroma. Cancer 58:1070–1075PubMedCrossRef Nakamura Y, Okamoto K, Tanimura A et al (1986) Elastase digestion and biochemical analysis of the elastin from an elastofibroma. Cancer 58:1070–1075PubMedCrossRef
5.
Zurück zum Zitat Järvi OH, Saxén AE, Hopsu-Havu VK, Wartiovaara JJ, Vaissalo VT (1969) Elastofibroma—a degenerative pseudotumor. Cancer 23:42–63PubMedCrossRef Järvi OH, Saxén AE, Hopsu-Havu VK, Wartiovaara JJ, Vaissalo VT (1969) Elastofibroma—a degenerative pseudotumor. Cancer 23:42–63PubMedCrossRef
6.
Zurück zum Zitat Stemmermann GN, Stout AP (1962) Elastofibroma dorsi. Am J Clin Pathol 37:499–506PubMed Stemmermann GN, Stout AP (1962) Elastofibroma dorsi. Am J Clin Pathol 37:499–506PubMed
7.
Zurück zum Zitat Nagamine N, Nohara Y, Ito E (1982) Elastofibroma in Okinawa. A clinicopathologic study of 170 cases. Cancer 50:1794–1805PubMedCrossRef Nagamine N, Nohara Y, Ito E (1982) Elastofibroma in Okinawa. A clinicopathologic study of 170 cases. Cancer 50:1794–1805PubMedCrossRef
8.
Zurück zum Zitat Machens HG, Mechtersheimer R, Göhring U et al (1992) Bilateral elastofibroma dorsi. Ann Thorac Surg 54:774–776PubMedCrossRef Machens HG, Mechtersheimer R, Göhring U et al (1992) Bilateral elastofibroma dorsi. Ann Thorac Surg 54:774–776PubMedCrossRef
9.
Zurück zum Zitat Batstone P, Forsyth L, Goodlad J (2001) Clonal chromosome aberrations secondary to chromosome instability in an elastofibroma. Cancer Genet Cytogenet 128:46–47PubMedCrossRef Batstone P, Forsyth L, Goodlad J (2001) Clonal chromosome aberrations secondary to chromosome instability in an elastofibroma. Cancer Genet Cytogenet 128:46–47PubMedCrossRef
10.
Zurück zum Zitat Hisaoka M, Hashimoto H (2006) Elastofibroma: clonal fibrous proliferation with predominant CD34-positive cells. Virchows Arch 448:195–199PubMedCrossRef Hisaoka M, Hashimoto H (2006) Elastofibroma: clonal fibrous proliferation with predominant CD34-positive cells. Virchows Arch 448:195–199PubMedCrossRef
11.
Zurück zum Zitat McComb EN, Feely MG, Neff JR et al (2001) Cytogenetic instability, predominantly involving chromosome 1, is characteristic of elastofibroma. Cancer Genet Cytogenet 126:68–72PubMedCrossRef McComb EN, Feely MG, Neff JR et al (2001) Cytogenetic instability, predominantly involving chromosome 1, is characteristic of elastofibroma. Cancer Genet Cytogenet 126:68–72PubMedCrossRef
12.
13.
Zurück zum Zitat Kindblom LG, Spicer SS (1982) Elastofibroma. A correlated light and electron microscopic study. Virchows Arch 396:127–140CrossRef Kindblom LG, Spicer SS (1982) Elastofibroma. A correlated light and electron microscopic study. Virchows Arch 396:127–140CrossRef
14.
Zurück zum Zitat Winkelmann RK, Sams WM Jr (1969) Elastofibroma. Report of a case with special histochemical and electron-microscopic studies. Cancer 23:406–415PubMedCrossRef Winkelmann RK, Sams WM Jr (1969) Elastofibroma. Report of a case with special histochemical and electron-microscopic studies. Cancer 23:406–415PubMedCrossRef
15.
Zurück zum Zitat Yamazaki K (2007) An ultrastructural and immunohistochemical study of elastofibroma: CD 34, MEF-2, prominin 2 (CD133), and factor XIIIa-positive proliferating fibroblastic stromal cells connected by Cx43-type gap junctions. Ultrastruct Pathol 3:209–219CrossRef Yamazaki K (2007) An ultrastructural and immunohistochemical study of elastofibroma: CD 34, MEF-2, prominin 2 (CD133), and factor XIIIa-positive proliferating fibroblastic stromal cells connected by Cx43-type gap junctions. Ultrastruct Pathol 3:209–219CrossRef
16.
Zurück zum Zitat Enjoji M, Sumiyoshi K, Sueyoshi K (1985) Elastofibromatous lesion of the stomach in a patient with elastofibroma dorsi. Am J Surg Pathol 9:233–237PubMedCrossRef Enjoji M, Sumiyoshi K, Sueyoshi K (1985) Elastofibromatous lesion of the stomach in a patient with elastofibroma dorsi. Am J Surg Pathol 9:233–237PubMedCrossRef
17.
Zurück zum Zitat Saint-Paul MC, Musso S, Cardot-Leccia N et al (2003) Elastofibroma of the stomach. Pathol Res Pract 199:637–639PubMedCrossRef Saint-Paul MC, Musso S, Cardot-Leccia N et al (2003) Elastofibroma of the stomach. Pathol Res Pract 199:637–639PubMedCrossRef
18.
Zurück zum Zitat Goldblum JR, Beals T, Weiss SW (1992) Elastofibromatous change of the rectum. A lesion mimicking amyloidosis. Am J Surg Pathol 16:793–795PubMedCrossRef Goldblum JR, Beals T, Weiss SW (1992) Elastofibromatous change of the rectum. A lesion mimicking amyloidosis. Am J Surg Pathol 16:793–795PubMedCrossRef
19.
Zurück zum Zitat Sakatani T, Shomori K, Adachi H et al (2000) Elastofibroma of the sigmoid colon. Pathol Res Pract 196:205–207PubMed Sakatani T, Shomori K, Adachi H et al (2000) Elastofibroma of the sigmoid colon. Pathol Res Pract 196:205–207PubMed
20.
Zurück zum Zitat Märkl B, Kerwel TG, Langer E et al (2008) Elastosis of the colon and the ileum as polyp causing lesions: a study of six cases and review of the literature. Pathol Res Pract 204:395–399PubMedCrossRef Märkl B, Kerwel TG, Langer E et al (2008) Elastosis of the colon and the ileum as polyp causing lesions: a study of six cases and review of the literature. Pathol Res Pract 204:395–399PubMedCrossRef
21.
Zurück zum Zitat Kim SI, Kwak JH, Zachariah M et al (2007) TGF-beta-activated kinase 1 and TAK1-binding protein 1 cooperate to mediate TGF-beta1-induced MKK3-p38 MAPK activation and stimulation of type I collagen. Am J Physiol Renal Physiol 292:F1471–F1478PubMedCrossRef Kim SI, Kwak JH, Zachariah M et al (2007) TGF-beta-activated kinase 1 and TAK1-binding protein 1 cooperate to mediate TGF-beta1-induced MKK3-p38 MAPK activation and stimulation of type I collagen. Am J Physiol Renal Physiol 292:F1471–F1478PubMedCrossRef
22.
Zurück zum Zitat Wang L, Ma R, Flavell RA et al (2002) Requirement of mitogen-activated protein kinase kinase 3 (MKK3) for activation of p38alpha and p38delta MAPK isoforms by TGF-beta 1 in murine mesangial cells. J Biol Chem 277:47257–47262PubMedCrossRef Wang L, Ma R, Flavell RA et al (2002) Requirement of mitogen-activated protein kinase kinase 3 (MKK3) for activation of p38alpha and p38delta MAPK isoforms by TGF-beta 1 in murine mesangial cells. J Biol Chem 277:47257–47262PubMedCrossRef
23.
Zurück zum Zitat Kai K, Kitajima Y, Hiraki M et al (2007) Quantitative double-fluorescence immunohistochemistry (qDFIHC), a novel technology to assess protein expression: a pilot study analyzing 5-FU sensitive markers thymidylate synthase, dihydropyrimidine dehydrogenase and orotate phosphoribosyl transferases in gastric cancer tissue specimens. Cancer Lett 258:45–54PubMedCrossRef Kai K, Kitajima Y, Hiraki M et al (2007) Quantitative double-fluorescence immunohistochemistry (qDFIHC), a novel technology to assess protein expression: a pilot study analyzing 5-FU sensitive markers thymidylate synthase, dihydropyrimidine dehydrogenase and orotate phosphoribosyl transferases in gastric cancer tissue specimens. Cancer Lett 258:45–54PubMedCrossRef
24.
Zurück zum Zitat Minhajat R, Mori D, Yamasaki F et al (2006) Endoglin (CD105) expression in angiogenesis of colon cancer: analysis using tissue microarrays and comparison with other endothelial markers. Virchows Arch 448:127–134PubMedCrossRef Minhajat R, Mori D, Yamasaki F et al (2006) Endoglin (CD105) expression in angiogenesis of colon cancer: analysis using tissue microarrays and comparison with other endothelial markers. Virchows Arch 448:127–134PubMedCrossRef
25.
Zurück zum Zitat Minhajat R, Mori D, Yamasaki F et al (2006) Organ-specific endoglin (CD105) expression in the angiogenesis of human cancers. Pathol Int 56:717–723PubMedCrossRef Minhajat R, Mori D, Yamasaki F et al (2006) Organ-specific endoglin (CD105) expression in the angiogenesis of human cancers. Pathol Int 56:717–723PubMedCrossRef
26.
Zurück zum Zitat Okada K, Satoh T, Fujimoto K et al (2004) Interaction between morphology and angiogenesis in human early colorectal cancers. Pathol Int 54:490–497PubMedCrossRef Okada K, Satoh T, Fujimoto K et al (2004) Interaction between morphology and angiogenesis in human early colorectal cancers. Pathol Int 54:490–497PubMedCrossRef
27.
Zurück zum Zitat Piao M, Tokunaga O (2006) Significant expression of endoglin (CD105), TGFbeta-1 and TGFbeta R-2 in the atherosclerotic aorta: an immunohistological study. J Atheroscler Thromb 13(2):82–89PubMed Piao M, Tokunaga O (2006) Significant expression of endoglin (CD105), TGFbeta-1 and TGFbeta R-2 in the atherosclerotic aorta: an immunohistological study. J Atheroscler Thromb 13(2):82–89PubMed
28.
Zurück zum Zitat Gun BD, Bahadir B, Behzatoglu K et al (2007) Elastofibroma: a clinicopathologic and immunohistochemical study of seven cases and literature review. APMIS 115:115–119PubMedCrossRef Gun BD, Bahadir B, Behzatoglu K et al (2007) Elastofibroma: a clinicopathologic and immunohistochemical study of seven cases and literature review. APMIS 115:115–119PubMedCrossRef
Metadaten
Titel
Active neovascularization and possible vascular-centric development of gastric and periscapular elastofibromas
verfasst von
Keita Kai
Kenichiro Kusano
Masashi Sakai
Masanobu Tabuchi
Seiji Yunotani
Kohji Miyazaki
Osamu Tokunaga
Publikationsdatum
01.02.2009
Verlag
Springer-Verlag
Erschienen in
Virchows Archiv / Ausgabe 2/2009
Print ISSN: 0945-6317
Elektronische ISSN: 1432-2307
DOI
https://doi.org/10.1007/s00428-008-0722-6

Weitere Artikel der Ausgabe 2/2009

Virchows Archiv 2/2009 Zur Ausgabe

Neu im Fachgebiet Pathologie

Molekularpathologische Untersuchungen im Wandel der Zeit

Open Access Biomarker Leitthema

Um auch an kleinen Gewebeproben zuverlässige und reproduzierbare Ergebnisse zu gewährleisten ist eine strenge Qualitätskontrolle in jedem Schritt des Arbeitsablaufs erforderlich. Eine nicht ordnungsgemäße Prüfung oder Behandlung des …

Vergleichende Pathologie in der onkologischen Forschung

Pathologie Leitthema

Die vergleichende experimentelle Pathologie („comparative experimental pathology“) ist ein Fachbereich an der Schnittstelle von Human- und Veterinärmedizin. Sie widmet sich der vergleichenden Erforschung von Gemeinsamkeiten und Unterschieden von …

Gastrointestinale Stromatumoren

Open Access GIST CME-Artikel

Gastrointestinale Stromatumoren (GIST) stellen seit über 20 Jahren ein Paradigma für die zielgerichtete Therapie mit Tyrosinkinaseinhibitoren dar. Eine elementare Voraussetzung für eine mögliche neoadjuvante oder adjuvante Behandlung bei …

Personalisierte Medizin in der Onkologie

Aufgrund des erheblichen technologischen Fortschritts in der molekularen und genetischen Diagnostik sowie zunehmender Erkenntnisse über die molekulare Pathogenese von Krankheiten hat in den letzten zwei Jahrzehnten ein grundlegender …